See more : Home Pottery Public Company Limited (HPT.BK) Income Statement Analysis – Financial Results
Complete financial analysis of G Medical Innovations Holdings Ltd (GMVD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of G Medical Innovations Holdings Ltd, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- FAR Intl Hldg Grp Co Ltd (2516.HK) Income Statement Analysis – Financial Results
- SBI Holdings, Inc. (8473.T) Income Statement Analysis – Financial Results
- Arena Events Group plc (ARE.L) Income Statement Analysis – Financial Results
- Thai Metal Drum Manufacturing Public Company Limited (TMD.BK) Income Statement Analysis – Financial Results
- Canlan Ice Sports Corp. (ICE.TO) Income Statement Analysis – Financial Results
G Medical Innovations Holdings Ltd (GMVD)
About G Medical Innovations Holdings Ltd
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | 4.42M | 5.06M | 4.90M | 5.53M | 3.06M | 109.00K | 0.00 |
| Cost of Revenue | 3.64M | 3.56M | 4.23M | 5.75M | 4.03M | 1.16M | 0.00 |
| Gross Profit | 784.00K | 1.50M | 667.00K | -223.00K | -969.00K | -1.05M | 0.00 |
| Gross Profit Ratio | 17.74% | 29.70% | 13.61% | -4.04% | -31.65% | -959.63% | 0.00% |
| Research & Development | 2.29M | 1.68M | 1.32M | 2.55M | 243.00K | 186.00K | 0.00 |
| General & Administrative | 24.86M | 9.01M | 7.66M | 10.00M | 12.61M | 24.01M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 3.46M | 664.00K | 356.00K | 0.00 |
| SG&A | 24.86M | 9.01M | 7.66M | 10.00M | 13.27M | 24.36M | 0.00 |
| Other Expenses | 1.05M | 854.00K | 3.70M | 0.00 | 2.70M | 0.00 | 0.00 |
| Operating Expenses | 28.19M | 11.54M | 12.67M | 12.56M | 16.22M | 25.48M | 0.00 |
| Cost & Expenses | 31.83M | 15.10M | 16.90M | 18.30M | 28.69M | 26.63M | 0.00 |
| Interest Income | 0.00 | 870.00K | 344.00K | 263.00K | 858.00K | 282.00K | 0.00 |
| Interest Expense | 0.00 | 4.49M | 750.00K | 3.85M | 995.00K | 923.00K | 0.00 |
| Depreciation & Amortization | -10.34M | 1.00M | 3.61M | 2.01M | 2.61M | 176.00K | 22.82K |
| EBITDA | -37.75M | -9.04M | -8.40M | -12.52M | -13.71M | -26.06M | 0.00 |
| EBITDA Ratio | -854.10% | -178.67% | -171.39% | -226.49% | -447.88% | -23,911.01% | 0.00% |
| Operating Income | -27.41M | -10.04M | -12.00M | -14.53M | -16.33M | -26.24M | 0.00 |
| Operating Income Ratio | -620.14% | -198.44% | -244.98% | -262.87% | -533.18% | -24,072.48% | 0.00% |
| Total Other Income/Expenses | 13.47M | -3.62M | -702.00K | -3.58M | -137.00K | -923.00K | 0.00 |
| Income Before Tax | -13.94M | -14.89M | -12.71M | -16.36M | -17.32M | -27.16M | 0.00 |
| Income Before Tax Ratio | -315.43% | -294.40% | -259.31% | -296.11% | -565.68% | -24,919.27% | 0.00% |
| Income Tax Expense | 16.00K | -3.00K | -18.00K | -857.00K | -345.00K | 85.00K | 0.00 |
| Net Income | -13.96M | -14.89M | -12.69M | -15.51M | -16.98M | -27.25M | 0.00 |
| Net Income Ratio | -315.79% | -294.35% | -258.94% | -280.60% | -554.41% | -24,997.25% | 0.00% |
| EPS | 0.00 | -45.89 | -60.40 | -7.00 | -8.60 | -20.39 | 0.00 |
| EPS Diluted | 0.00 | -45.89 | -60.40 | -7.00 | -8.60 | -20.39 | 0.00 |
| Weighted Avg Shares Out | 0.00 | 324.45K | 210.07K | 2.21M | 1.97M | 1.34M | 71.11M |
| Weighted Avg Shares Out (Dil) | 0.00 | 324.45K | 210.07K | 2.21M | 1.97M | 1.34M | 71.11M |
G Medical Innovations to announce receiving of 2 (two) granted patents from the USPTO for its Prizma care and other physiological sensors developed by the company.
Trending Penny Stocks For Your Watchlist Next Week
What to Know About Buying Penny Stocks on June 21st
4 Penny Stocks Up Big With The Stock Market Down Today; Time To Buy?
G Medical Innovations Stock (GMVD): Why The Price Substantially Went Up
7 Short Squeeze Penny Stocks To Buy For Under $5 Right Now
G Medical Innovations Stock (GMVD): Why The Price Surged Today
Short Squeeze Penny Stocks To Buy Now? 4 To Watch Under $5
G Medical Innovations: A Hidden Med-Tech Gem
Top 3 Penny Stocks For Your Weekly Watchlist in September
Source: https://incomestatements.info
Category: Stock Reports